Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Non-Current Debt (2023 - 2025)

Utah Medical Products has reported Non-Current Debt over the past 8 years, most recently at $225000.0 for Q4 2025.

  • Quarterly results put Non-Current Debt at $225000.0 for Q4 2025, down 20.21% from a year ago — trailing twelve months through Dec 2025 was $225000.0 (down 20.21% YoY), and the annual figure for FY2025 was $225000.0, down 20.21%.
  • Non-Current Debt for Q4 2025 was $225000.0 at Utah Medical Products, down from $241000.0 in the prior quarter.
  • Over the last five years, Non-Current Debt for UTMD hit a ceiling of $295000.0 in Q4 2023 and a floor of $225000.0 in Q4 2025.
  • Median Non-Current Debt over the past 3 years was $261500.0 (2024), compared with a mean of $260750.0.
  • Biggest five-year swings in Non-Current Debt: fell 4.41% in 2024 and later fell 20.21% in 2025.
  • Utah Medical Products' Non-Current Debt stood at $295000.0 in 2023, then decreased by 4.41% to $282000.0 in 2024, then fell by 20.21% to $225000.0 in 2025.
  • The last three reported values for Non-Current Debt were $225000.0 (Q4 2025), $241000.0 (Q3 2025), and $282000.0 (Q4 2024) per Business Quant data.